|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.29 USD | +4.75% |
|
-0.94% | +17.04% |
| May. 09 | Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M | MT |
| May. 09 | Transcript : ProPhase Labs, Inc., Q1 2024 Earnings Call, May 09, 2024 |
ProPhase LLC announced that Kris Kuhner has joined the company to head business development. Kuhner has over 14 years of industry experience in pharmaceutical and clinical research. Kuhner joins as vice president of business development to build on ProPhase's recent commercial successes in partnering to deliver highly customized solutions that support clinical trials in over 60 countries, in all phases, across 18 primary indications.
Kuhner worked for Astra Zeneca, Wyeth and ICON.
| 1st Jan change | Capi. | |
|---|---|---|
| +17.04% | 91.13M | |
| -15.77% | 8.49B | |
| +60.25% | 4.08B | |
| -43.01% | 2.42B | |
| -9.98% | 2.42B | |
| -3.24% | 2.33B | |
| -3.40% | 2.01B | |
| -19.79% | 1.53B | |
| -40.57% | 1.26B | |
| +9.11% | 1.07B |
PROPHASE LABS, INC. 